HHS Overrules FDA On Plan B OTC, Sends Teva Back To Drawing Board
This article was originally published in The Pink Sheet Daily
Executive Summary
HHS Secretary Sebelius’ override appears to set a precedent of HHS intervention in an FDA product review.
You may also be interested in...
US FDA Independence May Be In The Eye Of The Beholder
Former commissioners continue push to move FDA out of HHS, but the alternative could create a different kind of political influence rather than eliminate it.
Panel Of Former US FDA Commissioners Make Renewed Call For Independent Agency
Former FDA heads reflected on instances when they experienced pressure from their higher-ups; speakers also offered praise for the job Commissioner Scott Gottlieb is doing at the agency.
Gottlieb's Confirmation: He's Willing To Disagree With Trump, Sec. Price
Democrats test US FDA commissioner nominee's willingness to defend agency independence during confirmation hearing and probe potential conflicts of interest.